Get the Stockscreener App
3.47
2.25%
-0.08
After Hours:
3.45
-0.02
-0.58%
Ac Immune Sa stock is traded at $3.47, with a volume of 299.86K.
It is down -2.25% in the last 24 hours and up +42.80% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$3.55
Open:
$3.55
24h Volume:
299.86K
Relative Volume:
1.60
Market Cap:
$348.42M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-4.8908
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
-1.98%
1M Performance:
+42.80%
6M Performance:
+122.44%
1Y Performance:
+4.52%
1-Day Range:
$3.45
$3.69
1-Week Range:
$3.4101
$3.80
52-Week Range:
$1.4299
$3.99
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
3.47 | 357.13M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Will AC Immune SA stock recover after recent drop2025 Market Overview & Precise Buy Zone Tips - newser.com
Can AC Immune SA stock continue upward trendWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
How resilient is AC Immune SA stock in market downturnsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Detecting price anomalies in AC Immune SA with AIBond Market & Long-Term Safe Investment Plans - newser.com
How to escape a deep drawdown in AC Immune SAJuly 2025 PostEarnings & Verified Short-Term Plans - newser.com
How to read the order book for AC Immune SAWeekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Why analysts remain bullish on AC Immune SA stock2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Detecting support and resistance levels for AC Immune SA2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Trend analysis for AC Immune SA this weekQuarterly Performance Summary & Smart Allocation Stock Tips - newser.com
AC Immune SA Hits New 52-Week High of USD 3.99 - Markets Mojo
AC Immune SA stock chart pattern explainedBear Alert & Momentum Based Trading Signals - newser.com
Q3 Earnings Estimate for AC Immune Issued By Leerink Partnrs - Defense World
Q3 Earnings Forecast for AC Immune Issued By Leerink Partnrs - MarketBeat
Should you hold or exit AC Immune SA nowPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Multi factor analysis applied to AC Immune SAMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
How analysts rate AC Immune SA stock today2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Real time alert setup for AC Immune SA performanceWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Is AC Immune SA stock a buy for dividend growthPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Why AC Immune (ACIU) Is Up 15.8% After Promising Early Trial Data for Alzheimer’s Vaccine Candidate - Yahoo Finance
Does AC Immune SA fit your quant trading modelJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com
Why AC Immune SA (IMR) stock signals breakout potentialMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
AC Immune's (ACIU) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
AC Immune (ACIU) Is Up 24.2% After Positive ACI-35.030 Trial Publication in Alzheimer's Disease - simplywall.st
What analysts say about AC Immune SA IMR stockMean Reversion Trades & Rapid Portfolio Gain - earlytimes.in
AC Immune Gears Up For Pipeline MilestonesWill Upcoming Data Catalysts Spark Investor Interest? - RTTNews
AC Immune SA Stock Analysis and ForecastTrade Execution Strategies & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Is AC Immune SA trending in predictive chart modelsJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
AC Immune Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
How AC Immune SA stock performs in stagflationMarket Activity Report & Entry Point Confirmation Signals - newser.com
Using economic indicators to assess AC Immune SA potentialBuy Signal & Expert Curated Trade Ideas - newser.com
Can AC Immune SA hit a new high this monthTrade Ideas & Fast Moving Trade Plans - newser.com
AC Immune Leads Our Trio Of Promising Penny Stocks - Yahoo Finance
AC Immune (NASDAQ:ACIU) Trading 3% HigherShould You Buy? - MarketBeat
What drives AC Immune SA stock priceLarge Cap Stability Picks & Superior Capital Appreciation - earlytimes.in
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):